Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01379222 · ClinicalTrials.gov registry record · NA
Endurant Stent Graft System Post Approval Study (ENGAGE PAS)
A NA study, sponsored by Medtronic Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT01379222 is a NA study that has completed, run by Medtronic Cardiovascular. The registered enrollment target is 178 participants.
The verdict
NCT01379222, a NA study, has completed, sponsored by Medtronic Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
The purpose of the study is to demonstrate the long term safety and effectiveness of the Endurant Stent Graft System for the endovascular treatment of infrarenal abdominal aortic aneurysms in a post-approval environment, through the endpoints established in this protocol. The clinical objective of the study is to evaluate the long term safety and effectiveness of the Endurant Stent Graft System assessed at 5 years through freedom from Aneurysm-Related Mortality (ARM).
Interventions
- DEVICE Endurant Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2011-08 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01379222
The ClinicalTrials.gov registry entry for NCT01379222 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiovascular, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endurant Stent Graft System is the first listed.
NCT01379222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01379222 about?
NCT01379222 is a clinical study titled "Endurant Stent Graft System Post Approval Study (ENGAGE PAS)". The purpose of the study is to demonstrate the long term safety and effectiveness of the Endurant Stent Graft System for the endovascular treatment of infrarenal abdominal aortic aneurysms in a post-approval environment, through the endpoints established in this protocol. The clinical objective of ...
What is the current status of trial NCT01379222?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2011-08. Estimated completion is 2017-12.
What interventions are being tested in trial NCT01379222?
The interventions under investigation include: Endurant Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT01379222?
This trial is sponsored by Medtronic Cardiovascular, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.